American Well Corporation (AMWL) FinancialsAMWLFinancialAmerican Well Corporation

American Well Corporation (AMWL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Platform Subscription, accounting for 49.4% of total sales, equivalent to $25.71M. Other significant revenue streams include Visits and Other. Understanding this composition is critical for investors evaluating how AMWL navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, American Well Corporation maintains a gross margin of 39.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -19.60%, while the net margin is -18.49%. These profitability ratios, combined with a Return on Equity (ROE) of -31.01%, provide a clear picture of how effectively AMWL converts its operational activities into shareholder value.

In the context of the broader market, AMWL competes directly with industry leaders such as CMRC and GDEV. With a market capitalization of $211.76M, it holds a leading position in the sector. When comparing efficiency, AMWL's gross margin of 39.48% stands against CMRC's 73.45% and GDEV's 65.43%. Such benchmarking helps identify whether American Well Corporation is trading at a premium or discount relative to its financial performance.

In Q2 2026, American Well reported total revenue of $52 million, exceeding analysts' expectations of $49.7 million. The gross margin has improved to 39.48%, reflecting operational efficiency. The company has also raised its full-year adjusted EBITDA guidance, indicating confidence in future performance.